Credentialing

 

North Central Cancer Treatment Group (NCCTG)

Activated protocol list Closed protocol list

 

ALL NCCTG radiotherapy facilities must complete the IROC Houston 3D benchmark case, additional credentialing may be required for specific protocols.

N0577 --- Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma.
    Link to Protocols
   
   

Note: If you need help with the protocol links, please contact the NCCTG Operations Office or the CTSU Help Desk (1-888-823-5923 or ctsucontact@westat.com)